L.M. Havekes

722 total citations
26 papers, 610 citations indexed

About

L.M. Havekes is a scholar working on Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, L.M. Havekes has authored 26 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Cancer Research and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in L.M. Havekes's work include Cancer, Lipids, and Metabolism (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Cholesterol and Lipid Metabolism (5 papers). L.M. Havekes is often cited by papers focused on Cancer, Lipids, and Metabolism (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Cholesterol and Lipid Metabolism (5 papers). L.M. Havekes collaborates with scholars based in Netherlands, Belgium and Finland. L.M. Havekes's co-authors include Peter de Knijff, Marion J. Gijbels, M. Rosseneu, Dorret I. Boomsma, Menno P.J. de Winther, Lianne S.M. Boesten, R.R. Frants, Ulrike Beisiegel†, J.A. Gevers Leuven and Jørgen Jespersen and has published in prestigious journals such as Journal of the American College of Cardiology, Biomaterials and Biochemical and Biophysical Research Communications.

In The Last Decade

L.M. Havekes

26 papers receiving 597 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
L.M. Havekes 235 198 136 115 102 26 610
Birming Wong 169 0.7× 220 1.1× 257 1.9× 47 0.4× 104 1.0× 7 647
P.H. Rolland 186 0.8× 65 0.3× 146 1.1× 245 2.1× 59 0.6× 37 830
Feras Hantash 337 1.4× 169 0.9× 263 1.9× 251 2.2× 82 0.8× 35 1.0k
Miriam Lee‐Rueckert 420 1.8× 204 1.0× 315 2.3× 31 0.3× 259 2.5× 42 996
Atsuko Abiko 201 0.9× 339 1.7× 286 2.1× 70 0.6× 31 0.3× 26 795
Mathilde Dubois 179 0.8× 90 0.5× 257 1.9× 105 0.9× 30 0.3× 21 621
Yanjuan Zhu 76 0.3× 122 0.6× 225 1.7× 28 0.2× 73 0.7× 23 655
Carole Van der Donckt 209 0.9× 39 0.2× 216 1.6× 57 0.5× 235 2.3× 12 755
Eio Koh 63 0.3× 57 0.3× 257 1.9× 69 0.6× 204 2.0× 32 692
Iwona Wybrańska 102 0.4× 88 0.4× 327 2.4× 81 0.7× 67 0.7× 44 739

Countries citing papers authored by L.M. Havekes

Since Specialization
Citations

This map shows the geographic impact of L.M. Havekes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.M. Havekes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.M. Havekes more than expected).

Fields of papers citing papers by L.M. Havekes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.M. Havekes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.M. Havekes. The network helps show where L.M. Havekes may publish in the future.

Co-authorship network of co-authors of L.M. Havekes

This figure shows the co-authorship network connecting the top 25 collaborators of L.M. Havekes. A scholar is included among the top collaborators of L.M. Havekes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.M. Havekes. L.M. Havekes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krom, Yvonne D., Nuno Pires, J. Wouter Jukema, et al.. (2006). Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists. Cardiovascular Research. 73(1). 217–226. 18 indexed citations
2.
Boesten, Lianne S.M., et al.. (2005). Tumor necrosis factor-? promotes atherosclerotic lesion progression in APOE*3-leiden transgenic mice. Cardiovascular Research. 66(1). 179–185. 99 indexed citations
3.
Thüsen, Jan H. von der, et al.. (2005). Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer. Atherosclerosis. 183(2). 244–250. 41 indexed citations
4.
Pires, Nuno, Margreet R. de Vries, L.M. Havekes, et al.. (2005). Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(ε-caprolactone) stent cuff. Biomaterials. 26(26). 5386–5394. 54 indexed citations
5.
Neale, Michael C., Peter de Knijff, L.M. Havekes, & Dorret I. Boomsma. (2000). ApoE polymorphism accounts for only part of the genetic variation in quantitative ApoE levels. Genetic Epidemiology. 18(4). 331–340. 29 indexed citations
6.
Havekes, L.M., Hans van der Boom, J.J. Emeis, & P. Hans. (2000). New HMG-CoA reductase inhibitor ZD4522 lowers plasma lipids and VLDL production in APOE*3Leiden transgenic mice. Atherosclerosis. 151(1). 172–172. 4 indexed citations
7.
Winther, Menno P.J. de, et al.. (2000). Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis.. PubMed. 22(2-3). 85–91. 11 indexed citations
8.
Gijbels, Marion J., et al.. (2000). Alternative method for quantification of atherosclerosis. Atherosclerosis. 151(1). 172–172. 5 indexed citations
9.
Römer, Tjeerd J., H.P.J. Buschman, G.J. Puppels, et al.. (1998). Raman spectroscopy provides chemical mappings of atherosclerotic plaques in APOE•3 leiden transgenic mice. Journal of the American College of Cardiology. 31. 500–501. 1 indexed citations
10.
Leppänen, Pia, et al.. (1997). 1.P.87 Atherosclerotic lesions in ApoE3-Leiden transgenic mice. Atherosclerosis. 134(1-2). 34–35. 2 indexed citations
11.
Kromhout, Daan, et al.. (1996). The effect of 26 years of habitual fish consumption on serum lipid and lipoprotein levels (the Zutphen study).. Nutrition Metabolism and Cardiovascular Diseases. 6. 65–71. 11 indexed citations
12.
Boomsma, Dorret I., H.J.M. Kempen, J.A. Gevers Leuven, et al.. (1996). Genetic analysis of sex and generation differences in plasma lipid, lipoprotein, and apolipoprotein levels in adolescent twins and their parents. Genetic Epidemiology. 13(1). 49–60. 51 indexed citations
13.
Duijn, Cornelia M. van, Hanneke Meijer, J. C. M. Witteman, et al.. (1996). 315 Estrogen, apolipoprotein E and the risk of Alzheimer's Disease. Neurobiology of Aging. 17(4). S79–S80. 13 indexed citations
14.
Gijbels, Marion J., et al.. (1995). Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding. Atherosclerosis. 112(2). 237–243. 37 indexed citations
15.
Ehnholm, Christian, Peter de Knijff, L.M. Havekes, et al.. (1994). Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study. Atherosclerosis. 107(2). 229–238. 33 indexed citations
16.
Zhao, Shui‐Ping, A.H.M. Smelt, Arn M. J. M. van den Maagdenberg, et al.. (1994). Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 14(11). 1705–1716. 20 indexed citations
17.
Petrij, Fred, et al.. (1993). The Mouse Low-Density Lipoprotein Receptor Gene: cDNA Sequence and Exon-Intron Structure. Biochemical and Biophysical Research Communications. 191(3). 880–886. 32 indexed citations
18.
Knijff, Peter de, et al.. (1992). Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 12(12). 1371–1379. 61 indexed citations
19.
Knijff, Peter de, et al.. (1988). Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations.. Journal of Lipid Research. 29(12). 1621–1627. 63 indexed citations
20.
Cohen, Louis, et al.. (1987). Regulation of cholesterol metabolism in the liver in vivo and in vitro. Biochemical Society Transactions. 15(3). 339–340. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birming Wong Breakdown of academic impact, for papers by P.H. Rolland Breakdown of academic impact, for papers by Feras Hantash Breakdown of academic impact, for papers by Miriam Lee‐Rueckert Breakdown of academic impact, for papers by Atsuko Abiko Breakdown of academic impact, for papers by Mathilde Dubois Breakdown of academic impact, for papers by Yanjuan Zhu Breakdown of academic impact, for papers by Carole Van der Donckt Breakdown of academic impact, for papers by Eio Koh Breakdown of academic impact, for papers by Iwona Wybrańska
Rankless by CCL
2026